Adenocarcinoma of the esophagogastric junction: Neoadjuvant radiochemotherapy and radical surgery: Early results and toxicity

Strahlentherapie und Onkologie

Volumn 187, Issue 4, 2011, Pages 231-237

  Leibl, Bernhard J ^a,c   Vitz, Stephanie ^b,c   Schäfer, Wolfgang ^b,c   Alfrink, Martin ^b,c   Gschwendtner, Andreas ^a,c   Grabenbauer, Gerhard G ^b,c,d  

^a KLINIKUM COBURG   (Germany)

^b DiaCura Coburg ^*  (Germany)

^c Department of Molecular Pathology   (Germany)

^d DiaCura Coburg Radioonkologie und Strahlentherapie   (Germany)

Author keywords

Adenocarcinoma; Esophagus; Gastroesophageal junction; Radiochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CELL VIABILITY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; INFECTION; KAPLAN MEIER METHOD; LAPAROTOMY; LUNG TOXICITY; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE PERIOD; RADIATION DOSE; RETROSPECTIVE STUDY; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 79955721651     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2171-4     Document Type: Article

References (30)

1. J.A. Ajani P.F. Mansfield C.H. Crane 2005 Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 1237 44 15718321 10.1200/JCO.2005.01.305 1:CAS:528:DC%2BD2MXitl2gurY%3D (Pubitemid 46202281)
2. P. Balermpas M. Hambek O. Seitz 2009 Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck Strahlenther Onkol 185 775 81 20013086 10.1007/s00066-009-2092-7
3. N.M. Bösing J.W. Heise P.E. Goretzki 2004 Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery Chirurg 75 1088 97 15168031 10.1007/s00104-004-0840-x (Pubitemid 40125623)
4. T.B. Brunner A. Rupp W. Melzner 2008 Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost Strahlenther Onkol 184 15 22 18188518 10.1007/s00066-008-1787- 5
5. D. Cunningham W.H. Allum S.P. Stenning 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer New Engl J Med 355 11 20 16822992 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D
6. F. Fiorica D. Di Bona F. Schepis 2004 Preoperative chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis Gut 53 925 30 15194636 10.1136/gut.2003.025080 1:STN:280:DC%2BD2czitVCksA%3D%3D (Pubitemid 38824146)
7. K. Fujitani J.A. Ajani C.H. Crane 2007 Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastro-esophageal junction Ann Surg Oncol 14 2010 7 17342569 10.1245/s10434-006-9198-2 (Pubitemid 46988247)
8. S.E. Greer P.P. Goodney J.E. Sutton 2005 Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis Surgery 137 172 7 15674197 10.1016/j.surg.2004.06.033 (Pubitemid 40174424)
9. A. Jemal R. Siegel E. Ward 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
10. L. Jin C. Xiu-Feng Z. Bin 2009 Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma World J Gastroenterol 15 4962 8 10.3748/wjg.15.4962
11. F. Kamanger G.M. Dores W.F. Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 50 10.1200/JCO.2005.05.2308 (Pubitemid 46655601)
12. R.J. Korst A.L. Kansler J.L. Port 2006 Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal cancerinoma Ann Thorac Surg 82 480 4 16863749 10.1016/j.athoracsur. 2006.03.072 (Pubitemid 44080050)
13. K. Higuchi W. Koizumi S. Tanabe 2009 Current management of esophageal squamous-cell carcinoma in Japan and outher countries Gastrointest Cancer Res 3 153 61 19742141
14. G. Klautke R. Fietkau 2007 Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial Strahlenther Onkol. 183 163 9 17406796 10.1007/s00066-007-7702-7 (Pubitemid 46570763)
15. S. Law 2010 Esophagectomy without mortality: what can surgeons do? J Gastrointest Surg 14 Suppl1 101 7 10.1007/s11605-009-1028-y
16. H.K. Lee A.A. Vaporciyan J.D. Cox 2003 Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters Int J Radiat Oncol Biol Phys 57 1317 22 14630268 10.1016/S0360-3016(03)00583-2 (Pubitemid 37040930)
17. R.A. Malthaner R.K. Wong R.B. Rumble 2004 Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and metaanalysis BMC Med 24 35 52 10.1186/1741-7015-2-35 (Pubitemid 40251697)
18. M. McCurdy M.F. McAleer W. Wei 2010 Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancer Int J Radiat Oncol Biol Phys 76 816 23 19525073 10.1016/j.ijrobp.2009.02.059 1:CAS:528: DC%2BC3cXhvFClt70%3D
19. C. Pedrazzi F. Pasini S. Giacopuzzi 2004 Surgical treatment of gastro-esophageal junction adenocarcinoma: long-term results of a single Italian center G Chir 25 325 33
20. S. Ramela L. Trodella T.C. Mineo 2010 Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined modality therapy Int J Radiat Oncol Biol Phys 76 110 15 10.1016/j.ijrobp.2009.01.036
21. F. Roeder J. Friedrich C. Timke 2010 Correlation of patient related factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer Strahlenther Onkol 186 149 56 20165822 10.1007/s00066-010-2018-4
22. C. Wang H. Nakayama S. Sugahara 2009 Comparisons of dose-volume histograms for proton-beam versus 3D conformal x-ray therapy in patients with stage I non-small cell lung cancer Strahlenther Onkol 185 231 4 19370425 10.1007/s00066-009-1923-x
23. M. Wolf F. Zehentmayr M. Niyazi 2010 Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer Strahlenther Onkol 186 374 81 20582393 10.1007/s00066-010-2137-y
24. R.J. Siewert M. Feith M. Werner 2000 Adenocarcinoma of the esophageal junction: results for surgical therapy based on anatomical/topographic classification in 1002 consecutive patients Ann Surg 232 353 61 10.1097/00000658-200009000-00007
25. I. Sirak J. Petera J. Hatlova 2008 Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma Strahlenther Onkol 184 592 7 19016018 10.1007/s00066-008-1880- 9
26. M.S. Slater J. Holland D.O. Faigel 2001 Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 181 440 4 11448438 10.1016/S0002-9610(01)00601-8 1:STN:280:DC%2BD3MzpslaitA%3D%3D (Pubitemid 32614113)
27. M. Stahl M.K. Walz M. Stuschke 2009 Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 852 6 10.1200/JCO.2008.17.0506
28. J.D. Urschel H. Vasan 2003 A meta-analysis of randomized controlled trials that compared neo-adjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 538 43 12781882 10.1016/S0002-9610(03)00066-7 (Pubitemid 36627845)
29. T.N. Walsh M. Grennell S. Mansoor 2002 Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival Dis Esophagus 15 121 4 12220418 10.1046/j.1442-2050.2002.00214.x 1:STN:280:DC%2BD38vmtFylsw%3D%3D (Pubitemid 35264633)
30. Werner M, Höfler H. Pathologie. In: Roder JD, Stein HJ, Fink U (eds) Therapie gastrointestinaler Tumoren. Prinzipien der Chirurgischen Klinik und Poliklinik der Technischen Universität München. Berlin-Heidelberg-New York: Springer, 2000:46-53.